1 Little is known about the comparative plasma protein binding of the antimalarial agents quinine (QN) and its isomer quinidine (QD). We have examined the in vitro binding of QN and QD to albumin, a,-acid glycoprotein, normal human plasma, and maternal and foetal umbilical cord plasma. 2 QN was more avidly bound than QD, and binding of both drugs was substantially higher to a,-acid glycoprotein than to albumin, indicating that ot,-acid glycoprotein is the more important binding protein.3 Protein and drug concentration dependent binding was evident for both QN and QD. The unbound fraction of both drugs fell with increasing albumin (10 to 60 g 1-1) and a,r-acid glycoprotein (0.5 to 2.0 g 1-1) concentration, and there was a marked increase in unbound fraction of QN (6 to 19%) and QD (13 to 36%) in human plasma when drug concentrations were increased over the antimalarial therapeutic range (0.5 to 10 mg 1-1). 4 In human volunteer plasma, the unbound fractions of QN and QD were 7.5 ± 2.2% and 12.3 ± 2.3% respectively, whilst the unbound fractions for both drugs were significantly higher in maternal plasma (QN = 13.0 ± 5.4%, QD= 18.3 ± 2.5%) and significantly higher still in foetal umbilical cord plasma (QN = 25.7 10%, QD = 35 ± 5.3%).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.